Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Bridget Kelly1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.;2 Center for Drug Evaluation and Research, Food and Drug Administration,Silver Spring,USA.Correspondence[email protected]

https://orcid.org/0000-0002-8661-2694

Amie O’Donoghue2 Center for Drug Evaluation and Research, Food and Drug Administration,Silver Spring,USA.

Sarah Parvanta1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Vanessa Boudewyns1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Oluwamurewa Oguntimein2 Center for Drug Evaluation and Research, Food and Drug Administration,Silver Spring,USA.

Carla Bann1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Sue West1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Janice Tzeng1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Caroline Chandler1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Gabriel Madson1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

Lauren McCormack1 RTI International,701 13th Street NW, Ste. 750,Washington,DC20005,USA.

show all

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date